Development and evaluation of inhalable composite niclosamide-lysozyme particles: A broad-spectrum, patient-adaptable treatment for coronavirus infections and sequalae

Title
Development and evaluation of inhalable composite niclosamide-lysozyme particles: A broad-spectrum, patient-adaptable treatment for coronavirus infections and sequalae
Authors
Keywords
SARS CoV 2, Coronaviruses, COVID 19, Lysozyme, Powders, Virus testing, Antiviral therapy, Inflammation
Journal
PLoS One
Volume 16, Issue 2, Pages e0246803
Publisher
Public Library of Science (PLoS)
Online
2021-02-12
DOI
10.1371/journal.pone.0246803

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now